Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Thye Lim

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
The Lancet. Haematology|December 22, 2015
Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trialDaryl Tan, Colin Phipps, William Y K Hwang, et al.
Cancer Causes & Control : CCC|May 1, 2012
Sun exposure and risk of lymphoid neoplasms in SingaporeKin-Yoke Wong, Bee-Choo Tai, Sin-Eng Chia, et al.
Leukemia|February 16, 2020
Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphomaGeorg Lenz, Eliza Hawkes, Gregor Verhoef, et al.
Leukemia|January 10, 2024
Correction: Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphomaGeorg Lenz, Eliza Hawkes, Gregor Verhoef, et al.
Leukemia & Lymphoma|October 6, 2022
Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC studyBurhan Ferhanoglu, Tae Min Kim, Amado Karduss, et al.
The Lancet. Haematology|December 22, 2015
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysisSeok Jin Kim, Joon Young Choi, Seung Hyup Hyun, et al.
Experimental Hematology & Oncology|January 4, 2024
Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphomaBernard Ji Guang Chua, Chen Ee Low, Chun En Yau, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Role of Surveillance Imaging in Patients With Peripheral T-Cell LymphomaTiffany Tang, Zhengming Chen, Pannee Praditsuktavorn, et al.
JCO Oncology Practice|January 13, 2021
Early Outcomes of a National Cancer Center's Strategy Against COVID-19 Executed Through a Disease Outbreak Response TaskforceJin Wei Kwek, Jack J Chan, Ravindran Kanesvaran, et al.
Leukemia & Lymphoma|January 26, 2012
Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study GroupSeok Jin Kim, Joon Ho Moon, Hawk Kim, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
The Lancet. Haematology|December 22, 2015
Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trialDaryl Tan, Colin Phipps, William Y K Hwang, et al.
Cancer Causes & Control : CCC|May 1, 2012
Sun exposure and risk of lymphoid neoplasms in SingaporeKin-Yoke Wong, Bee-Choo Tai, Sin-Eng Chia, et al.
Leukemia|February 16, 2020
Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphomaGeorg Lenz, Eliza Hawkes, Gregor Verhoef, et al.
Leukemia|January 10, 2024
Correction: Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphomaGeorg Lenz, Eliza Hawkes, Gregor Verhoef, et al.
Leukemia & Lymphoma|October 6, 2022
Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC studyBurhan Ferhanoglu, Tae Min Kim, Amado Karduss, et al.
The Lancet. Haematology|December 22, 2015
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysisSeok Jin Kim, Joon Young Choi, Seung Hyup Hyun, et al.
Experimental Hematology & Oncology|January 4, 2024
Recent updates on central nervous system prophylaxis in patients with high-risk diffuse large B-cell lymphomaBernard Ji Guang Chua, Chen Ee Low, Chun En Yau, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Role of Surveillance Imaging in Patients With Peripheral T-Cell LymphomaTiffany Tang, Zhengming Chen, Pannee Praditsuktavorn, et al.
JCO Oncology Practice|January 13, 2021
Early Outcomes of a National Cancer Center's Strategy Against COVID-19 Executed Through a Disease Outbreak Response TaskforceJin Wei Kwek, Jack J Chan, Ravindran Kanesvaran, et al.
Leukemia & Lymphoma|January 26, 2012
Non-bacterial infections in Asian patients treated with alemtuzumab: a retrospective study of the Asian Lymphoma Study GroupSeok Jin Kim, Joon Ho Moon, Hawk Kim, et al.
Pageof 19